SCHEMBL11909416

SCHEMBL11909416

O=C(O)Cn1ncc2c(Cl)nc(Cl)nc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 4/20 0.46
KDM4E B2RXH2 2/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HSP90AA1 P07900 4/20 0.36
TRAP1 Q12931 4/20 0.36
HSP90AB1 P08238 1/20 0.36
HSP90B1 P14625 1/20 0.36
POLB P06746 1/20 0.35
NPC1 O15118 1/20 0.33
MITF O75030 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4D Q08499 1/20 0.33
P2RX7 Q99572 1/20 0.33
BCL6 P41182 1/20 0.33
PDE2A O00408 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23885052 0.78 KMO (0.42) KMOKDM4ETP53HPGDHSD17B10
SCHEMBL7919917 0.78 CYP1A2 (0.39) HSP90AA1TRAP1HSP90AB1HSP90B1SMN1; SMN2
SCHEMBL2189832 0.77 ADORA3 (0.43) KDM4ETP53HPGDHSD17B10HSP90AA1
SCHEMBL23055223 0.76 KMO (0.50) KMOKDM4ETP53HPGDHSD17B10
SCHEMBL17926576 0.76 HSP90AA1 (0.39) KDM4EHPGDHSD17B10HSP90AA1TRAP1
SCHEMBL2786472 0.75 ALDH1A1 (0.54) KDM4EHPGDHSD17B10HSP90AA1TRAP1
SCHEMBL31194508 0.75 ALDH1A1 (0.54) KDM4EHPGDHSD17B10HSP90AA1TRAP1
SCHEMBL12787612 0.75 KMO (0.38) KMOKDM4ETP53HPGDHSD17B10
SCHEMBL2786539 0.74 PDE1A (0.42) HSP90AA1TRAP1HSP90AB1HSP90B1NPC1
SCHEMBL7904205 0.74 PLK4 (0.41) KDM4EHPGDHSD17B10HSP90AA1TRAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741896-B2 Pyrazolopyrimidine derivatives MERCK PATENT GMBH (DE) 2014-06-03 US disclosed
US-20120208808-A1 PYRAZOLOPYRIMIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208808-A1 PYRAZOLOPYRIMIDINE DERIVATIVES PDPK1, PIK3R5, NLRP1 KMO 2456/4885KDM4E 3029/4885TP53 602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.